FC
SWTX

FORA Capital’s SpringWorks Therapeutics SWTX Stock Holding History

FORA Capital’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,775
Closed -$343K – 684
2025
Q1 		$343K Buy
+7,775
New +$358K 0.03% 387
2024
Q3 		– Sell
-17,417
Closed -$656K – 571
2024
Q2 		$656K Sell
17,417
-10,477
-38% -$441K 0.08% 262
2024
Q1 		$1.37M Buy
27,894
+4,870
+21% +$225K 0.11% 211
2023
Q4 		$840K Buy
+23,024
New +$601K 0.07% 265
2021
Q3 		– Sell
-1,546
Closed -$127K – 819
2021
Q2 		$127K Buy
+1,546
New +$117K 0.02% 538
2021
Q1 		– Sell
-5,197
Closed -$377K – 1083
2020
Q4 		$377K Buy
+5,197
New +$335K 0.06% 344
2020
Q3 		– Sell
-608
Closed -$26K – 969
2020
Q2 		$26K Buy
+608
New +$21.6K 0.01% 769

Other funds holding SWTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

FORA Capital's SWTX Position: Q2 2025 in Review

FORA Capital sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 7,775 shares — an estimated $343K sold.

FORA Capital first reported a position in SWTX in Q2 2020 and held it in 7 quarters. The position peaked at $1.37M in Q1 2024. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

  • FORA Capital reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
  • FORA Capital sold 7,775 SpringWorks Therapeutics shares in Q2 2025, an estimated $343K.
  • FORA Capital first reported a position in SpringWorks Therapeutics in Q2 2020 and held it in 7 quarters.
  • FORA Capital's SpringWorks Therapeutics position peaked at $1.37M in Q1 2024.
  • 223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on FORA Capital's 13F filing for Q2 2025, filed 13 Aug 2025.